Double Your Returns With These 4 Stocks About to Go Ex-Dividend (The Market Cap)

If you are unable to see the message below, click here to view.

You are receiving this newsletter as an opt-in subscriber of Investors Alley. Ensure you continue to get this valuable content by whitelisting us - click here to learn how. Follow these links to update your subscriber profile or opt-out of these emails.

Wednesday, September 24, 2014 Contact  |  Privacy

The End of Chemotherapy As We Know It - 581% Gains Could Be Yours! This crucial medical breakthrough promises to change how the world treats Leukemia! When word gets out - shares in this unknown company could shoot up 581% in just a few months! See why here...

FEATURE

Double Your Returns With These 4 Stocks About to Go Ex-Dividend Tim Plaehn's new "anti-dividend capture" strategy can help you benefit from the failed attempts of investors trying to grab a quick dividend. Here are four stocks to add to your portfolio right now to take advantage of others' miscues and boost your short-term returns. Click to read more

EDITOR'S PICKS Exclusive Report: Do you know what tech sector is about to boom? [ad] Value Investing: Buy These 3 Value Stocks in an Overbought Market OUR TOP INVESTING IDEAS 3 Oil and Gas Plays for Another Frigid Winter Early autumn often presents a prime period to pick up shares of oil and gas exploration and production (E&P) stocks. With many predicting another brutal winter across the country, oil and gas prices should soar. Here are Bret Jensen's three favorite stocks in this area. Click to read more Russell 2000 Death Cross: Ignore the Media and Start Buying If you've been watching the financial media this week, you probably heard the Russell 2000 was hit with the dreaded "death cross." The name alone is ominous enough to force the market into a selloff. But this technical pattern can actually be a great buying opportunity. Here's why. Click to read more Breakthrough medical device stock could make investors a fortune in 2014 [ad]

© Copyright 1998-2014, Investors Alley Corp. All rights reserved. See Privacy Policy and Terms of Use | Contact Us

 

If you enjoyed reading this email, click here to forward it to a friend or colleague.

You are receiving this message because you registered ignoble.experiment@arconati.us through INO.com Invite Sell - Apr 2014.
Click here to send us comments or questions regarding this mailing. Unsubscribe/update profile using link below.

This message from Investors Alley Corp. is being sent in full accordance with the CAN-SPAM Act.
We respect your privacy and, therefore, this email was sent directly from Investors Alley.  Please review our Privacy Statement and Terms of Use. 
If you no longer wish to receive emails from Investors Alley, please opt-out using the link below.

The opinions in this email and corresponding web sites are neither an offer nor a recommendation to buy or sell any security. Investors Alley Corp. and its affiliates may hold a position in any of the companies mentioned.  Investors Alley Corp. is not a registered investment firm nor a broker/dealer.  We urge you to always conduct your own research and due diligence and obtain professional advice before making any investment decision.

All information contained herein is copyright 2014, Investors Alley Corp.
Investors Alley Corporation | 41 Madison Avenue | 31st Floor | New York, NY  10010

Update Your Profile Information | Modify Subscription Settings or Unsubscribe From Emails